Northeast Financial Consultants’s ProMIS Neurosciences PMN Stock Holding History

Northeast Financial Consultants’s Portfolio PMN Stock Details PMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,000	Closed	-$191K	–	292
2024 Q1	$191K	Hold	4,000	–	–	0.01%	276
2023 Q4	$115K	Hold	4,000	–	–	0.01%	271
2023 Q3	$198K	Hold	4,000	–	–	0.01%	271
2023 Q2	$388K	Hold	4,000	–	–	0.02%	204
2023 Q1	$473K	Hold	4,000	–	–	0.03%	199
2022 Q4	$434K	Hold	4,000	–	–	0.03%	202
2022 Q3	$613K	Buy	+4,000	New	+$589K	0.04%	168

Other funds holding PMN

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

ABG

Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Hara Capital Bellevue, Washington $200M AUM 49.32% 1-Year Est. Return

IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return

Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return

CAM

Claret Asset Management Montreal, Quebec, Canada $837M AUM 25.51% 1-Year Est. Return

SSB

Sandy Spring Bank Olney, Maryland $2.38B AUM 8.14% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northeast Financial Consultants's PMN Position: Q2 2024 in Review

Northeast Financial Consultants sold out of ProMIS Neurosciences (PMN) in Q2 2024, closing a stake of 4,000 shares — an estimated $191K sold.

Northeast Financial Consultants first reported a position in PMN in Q3 2022 and held it in 7 quarters. The position peaked at $613K in Q3 2022. 14 funds tracked by Wall St. Rank hold PMN as of Q2 2024.

Northeast Financial Consultants reported no remaining ProMIS Neurosciences position as of Q2 2024 after selling out during the quarter.
Northeast Financial Consultants sold 4,000 ProMIS Neurosciences shares in Q2 2024, an estimated $191K.
Northeast Financial Consultants first reported a position in ProMIS Neurosciences in Q3 2022 and held it in 7 quarters.
Northeast Financial Consultants's ProMIS Neurosciences position peaked at $613K in Q3 2022.
14 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q2 2024.

Based on Northeast Financial Consultants's 13F filing for Q2 2024, filed 15 Aug 2024.